iLivTouch® Supports Dr. Oliver Patrón and the Team at Hospital Parque de Llevant in Full-Cycle Liver Disease Management
We are grateful for the trust of Dr. Oliver Patrón and the team at Hospital Parque de Llevant. Together, we are committed to advancing the early identification of high-risk liver disease populations in both primary and specialized healthcare settings.
With our iLivTouch®, we aim to empower healthcare professionals by providing fast, accurate, and effective support for prevention, diagnosis, and treatment decisions.
At Hisky Medical, we believe in making a meaningful impact in liver health, one partnership at a time.
Let’s shape the future of liver care together! 🌍💙
Picture from:
532 <Salut i Força Baleares> Page 33
https://lnkd.in/gvDP7sgS
Other News
Precise Stratification of MASLD Based on iLivTouch: Advantages of the TyG-BMI Index in Evaluating Hepatic Steatosis and Fibrosis
Hisky Medical's CelTouch Collaborates with Leading Hospitals to Launch the National-Level Project on Precision Diagnosis of Peripheral Pulmonary Lesions
Hisky Medical proudly participated in UEG Week 2025 in Berlin — one of Europe’s most influential gatherings in gastroenterology and hepatology
Hisky Medical Shines at ACG 2025: Innovative Technologies Lead the Future of Digestive and Liver Health with Highlights at Phoenix Venue
New Research: 5:2 Intermittent Fasting for MAFLD Management